The Effect of Female Gender in Renal Cell Carcinomas
Renal cell carcinoma accounts 85% of all renal tumors. In this study, we aimed to investigate the clinical and pathological results of female patients with RCCs and compare with male patients. The patients who underwent radical or partial nephrectomy were reviewed retrospectively. The clinical characteristics of male and female patients were analyzed and compared with age, tumor size, histological subtype, Fuhrman nuclear grade, and pathological T stage. There were 266 patients in the study. Of these patients; 181 patients (68.05%) were male and 85 patients (31.95%) were female. The female patients’ and male patients’ mean ages were 57.09±13.36 and 60.24±10.44 years (P=0.007), respectively. Tumor size was smaller in female patients than male patients with statistically significant association (5.69±3.20 and 6.97±3.67, P=0.046). According to the histological subtypes, female patients had a greater proportion of chromophobe RCC with 18.82% of the patients. Interestingly, papillary (12.56%) and sarcomatoid differentiation (6.01%) subtypes were predominantly seen in male patients. The proportion of localized disease (pT1-2) was 80% and 74.3% in female and male patients, grade 1 and 2 consist 61.16% and 48.63% of the female and male patients. The female patients with RCC had smaller tumors and presented at younger age than male patients. Further research and epidemiologic studies are needed to define the effect of gender in renal cell carcinomas.
Aron M, Nyugen MM, Stein RJ, Gill IS. Impact ofGender in Renal Cell Carcinoma: An Analysis of theSEER Database. Eur Urol 2008;54:133-42.
Ohno Y, Nakashima J, Nakagami Y, Satake N, Gondo T,Ohori M et al. Sex and the clinical value of body massindex in patients with clear cell renal cell carcinoma. Br JCancer 2013;109:1899-903.
Chen J, Shi B, Zhang D, Jiang X, Xu Z. The clinicalcharacteristics of renal cell carcinoma in female patients.Int J Urol 2009;16:554-7.
Hsieh P, Chang CH, Huang CP, Chen CC, Chen KL,Chang SS et al. The impact of gender and size on thepathology of small renal masses. Kaohsiung J Med Sci2012;28:369-372.
Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Pummer K et al. Renal cellcarcinoma stage migration in a single European centreover 25 years:effects on 5 and 10 year metastasis freesurvival. Int Urol Nephrol 2012;44:997-1004.
Lindblad P, Mellemgaard A, Schlehofer B, AdamiHO, McCredie M, McLaughlin JK et al. International renal-cell cancer study. V. Reproductivefactors,gynecologic operations and exogenous hormones.Int J Cancer 1995;61:192-8.
Kabat GC, Silvera SA, Miller AB, Rohan TE. A cohortstudy of reproductive and hormonal factors and renal cellcancer risk in women. Br J Cancer 2007;96:845-9.
Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z.2004 WHO classification of the renal tumors of theadults. Eur Urol 2006;49:798-805.
Edge SB, Byrd DR, Compton CC. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag, 2009:479-89.
Fuhrman SA, Lasky LC, Limas C. Prognosticsignificance of morphologic parameters in renal cellcarcinoma. Am J Surg Pathol 1982;6:655-3.
Lee S, Jeon HG, Kwak C, Kim HH, Byun SS, Lee SE, etal. Genderspecific clinicopathological features andsurvival in patients with renal cell carcinoma. BJUI2011;110:28-33.
Lee JE, Hankinson SE, Cho E. Reproductive factors andrisk of renal cell cancer: the Nurses’ Health Study. AM JEpidemiol 2009;169:1243-50.
Gago-Domingues M, Castelao JE, Yuan JM, Ross RK,Yu MC. Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev1999;8:999-1003.
Woldrich JM, Mallin K, Ritchey J, CarrolL PR, Kane CJ.Sex Differences in Renal Cell Cancer Presentation andSurvival: An Analysis of the National Canceer Database,1993-2004. J Urol 2008;179:1709-13.
Kim JM, Song PH, Kim HT, Park TC. The PrognosticFactors for Patients with pT1a Renal Cell Carcinoma.Korean J Urol 2010;51:233-8.
Nason GJ, McGuire BB, Kelly ME, MurphyTM, Looney AT, Byrne DP, et al. Clinicopathologicalanalysis of renal cell carcinoma demonstrates decreasingtumour grade over a 17-year period. Can Urol Assoc J2014;8:125-32.
|Issue||Vol 56, No 2 (2018)|
|Renal cell Carcinoma Gender|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|